![](/img/cover-not-exists.png)
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
Crisà, Elena, Cilloni, Daniela, Elli, Elena M., Martinelli, Vincenzo, Palumbo, Giuseppe A., Pugliese, Novella, Beggiato, Eloise, Frairia, Chiara, Cerrano, Marco, Lanzarone, Giuseppe, Marchetti, Monia,Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.15450
Date:
July, 2018
File:
PDF, 99 KB
english, 2018